Ranbaxy Case: A US Perspective

I should just mention that an interesting US comment on Ranbaxy UK Ltd and another v Warner-Lambert Company [2005] EWHC 2142 (Patents) (12 Oct 2005) appeared on Patent Baristas overnight. Stephen Albainy-Jenei reported the decision in “Pfizer wins one/Loses one in UK Suit over Lipitor” and added some useful information about the parallel litigation in the USA. In particular the note summarizes the prior art which makes it much easier to absorb the revocation part of Mr Justice Pumfrey’s decision. Anyone who wants to analyse the English case would benefit from reading Stephen’s note. It is also clear that the same issues arise in the American proceedings as in the revocation part of the Ranbaxy case and in Stephen’s view the decision in the US District Court is likely to go the same way. On verra.


About Jane Lambert

I am a barrister specializing in intellectual property, technology, media and entertainment and competition law. I specialize in helping SME (small and medium enterprises) protect and exploit their investment in brands, design, technology and the arts. SME require intellectual property (legal protection for their intellectual assets) at least as much as big business but their limited means restrict the way they can use it. Looking after such clients wisely requires skills and knowledge which have taken me years to learn.
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s